ENDURANT CAPITAL MANAGEMENT LP – Adaptimmune Therapeutics plc Transaction History
ENDURANT CAPITAL MANAGEMENT LP portfolio value:
$1.92M
portfolio value
ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:
-36.76%
quarter
Adaptimmune Therapeutics plc 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.95% | -35.54K shares | -1.17M | $1.08 | 1.78M |
| Q2 2022 | share | Decrease | -15.59% | -336.82K shares | -1.35M | $1.7 | 1.82M |
| Q1 2022 | share | Increase | +140.75% | 1.26M shares | 1.08M | $2.06 | 2.16M |
| Q4 2021 | share | Decrease | -2.17% | -19.90K shares | -1.37M | $3.87 | 897.57K |
| Q3 2021 | share | Decrease | -40.40% | -621.94K shares | -1.81M | $5.17 | 917.48K |
| Q2 2021 | share | Increase | +68.11% | 623.72K shares | 1.69M | $4.26 | 1.53M |
| Q1 2021 | share | Decrease | -15.07% | -162.46K shares | -949K | $5.31 | 915.71K |
| Q4 2020 | share | Increase | +87.67% | 503.67K shares | 1.22M | $5.39 | 1.07M |
| Q3 2020 | share | Increase | +18.92% | 91.39K shares | -251K | $7.98 | 574.50K |
| Q2 2020 | share | Increase | +202.27% | 323.27K shares | 4.40M | $10.01 | 483.10K |
| Q1 2020 | share | Increase | 0.00% | 159.82K shares | 435K | $2.72 | 159.82K |